Amicus Therapeutics, Inc. (FOLD): Small-Cap Biotech with Large Hedge Fund Ownership
Amicus Therapeutics, Inc. (NASDAQ:FOLD)'s lead drug candidate is migalastat, which targets Fabry disease.
Amicus Therapeutics Inc. (FOLD)
Market is closed
News
- First
- << Previous
- 51 - 60
- Next >>
Why Are Investors Excited About These 5 Stocks Today?
The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China's slowdown.
Why Valeant, Micron, and Three Other Stocks Are in Green Territory on Friday?
Oil went back to tumbling on Friday, with crude oil losing more than 3.5%. On the other hand, markets returned to positive territory, with major U.S. stock indexes trading slightly up.
Top Biotech Picks of Best-Performing Hedge Fund of 2015
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top of the list was biotech-focused hedge fund Perceptive...
Redmile Group's Top Q4 Moves as Its Long Positions Show Gains of 20% in 2015
Redmile Group is a San Francisco-based investment firm managed by Jeremy Green, which primarily focuses on the healthcare sector.
Five Cheap Healthcare Stocks Poised to Explode
Over the past few months the healthcare sector has undergone a roller coaster of a ride, especially in August and September when many investors got wary of the sector being overvalued, especially in terms...
The Smart Money Is Hoarding Shares of These 10 Healthcare Stocks: Part 1
Given elite hedge funds have filed their latest 13F's, we have an opportunity to analyze what hedge funds like and what they don't like.
Are Hedge Funds Dumping Amicus Therapeutics, Inc. (FOLD)?
The third-quarter stock market correction has turned out to resemble the situation observed during the Asian financial crisis of 1997.
Why Are These Four Stocks Making A Late Surge?
Shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Novavax, Inc.
Are The Gains In These Hot Monday Stocks Sustainable?
It’s a good Monday for investors of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV), Amicus Therapeutics, Inc. (NASDAQ:FOLD), and Oasis Petroleum Inc.
- First
- << Previous
- 51 - 60
- Next >>
Billionaire Hedge Funds
